Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure

NCT06578520 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Dapagliflozin

Sponsor

Fundación para la Investigación del Hospital Clínico de Valencia